The year in cardiology: coronary interventions
View Full Paper
Ask AI
Bookmark
Share
Key result
Pivotal 2019 studies demonstrated the value of complete revascularization in STEMI, the efficacy of newer drug-eluting stents, and the prognostic benefit of intravascular imaging in guiding PCI.
Why the study?
To summarise the findings of pivotal studies published in 2019 regarding treatment strategies and stent platforms in obstructive CAD and discuss their impact on clinical practice.
Design
Review of pivotal studies published in 2019
Authors
Discussion
Loading...
Member takes
Implication
Reinforces complete revascularization and imaging-guided PCI; extends 2019 trial data while leaving optimal real-world strategies open.
Structured PICO
P
Population
A comprehensive review of pivotal clinical trials published in 2019 focusing on coronary interventions, adjunctive pharmacotherapy, and invasive diagnostic tools for patients with coronary artery disease.
I
Intervention
Various percutaneous coronary intervention (PCI) strategies, novel stent platforms, and adjunctive pharmacotherapies.
C
Comparator
Optimal medical therapy, surgical revascularization (CABG), or alternative PCI strategies.
This annual review synthesizes key 2019 clinical trials in interventional cardiology, providing updated perspectives on revascularization versus medical therapy, complex PCI, and adjunctive pharmacotherapy.
Limitations
- High crossover rates in some of the included trials (e.g., ISCHEMIA, DECISION-CTO)
- Some included studies were underpowered due to premature termination or lower than expected event rates (e.g., DECISION-CTO, MR-INFORM, CROSS-AMI)
Cite This Study
Baumbach et al. (2020) conducted a review in Coronary artery disease. Percutaneous coronary intervention and adjunctive therapies was evaluated. Pivotal 2019 studies demonstrated the value of complete revascularization in STEMI, the efficacy of newer drug-eluting stents, and the prognostic benefit of intravascular imaging in guiding PCI.
View Full Paper
Ask AI
Bookmark
Share